title: Genetic deletion of the MT1 or MT2 melatonin receptors abrogates methamphetamine-induced reward in C3H/HeN mice.
abstract: The drug of abuse methamphetamine (METH) is known for its ability to enhance reward responses. The rewarding properties of psychostimulants have been shown to vary across time of day in mice. The goal of this study was to determine the role of the MT1 and MT2 melatonin receptors in METH-induced reward, as measured by the conditioned place preference (CPP) paradigm during the light and dark phases. C3H/HeN wild-type mice were trained for METH-induced CPP at either ZT 6-8 (ZT: Zeitgeber time; ZT 0=lights on), when endogenous melatonin levels are low, or ZT 19-21, when melatonin levels are high. These time points also correspond to the high and low points for expression of the circadian gene Period1, respectively. The locomotor response to METH (1.2mg/kg, ip) treatment was of similar magnitude at both times; however only C3H/HeN mice conditioned to METH at ZT 6-8 developed a place preference. C3H/HeN mice with a genetic deletion of either the MT1 (MT1KO) or MT2 (MT2KO) receptor tested at ZT 6-8 or ZT 19-21 did not develop a place preference for METH, though both showed a similar increase in locomotor activity following METH treatment when compared to wild-type mice. We conclude that in our mouse model METH-induced CPP is dependent on time of day and the presence of the MT1 or MT2 receptors, suggesting a role for melatonin in METH-induced reward.
authors.affiliation: Department of Pharmacology & Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, United States.
authors.forename: Shannon J
authors.initials: SJ
authors.lastname: Clough
authors.affiliation: Department of Pharmacology & Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, United States.
authors.forename: Anthony J
authors.initials: AJ
authors.lastname: Hutchinson
authors.affiliation: Department of Physiology and Biophysics, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, United States.
authors.forename: Randall L
authors.initials: RL
authors.lastname: Hudson
authors.affiliation: Department of Pharmacology & Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, United States. Electronic address: mdubo@buffalo.edu.
authors.forename: Margarita L
authors.initials: ML
authors.lastname: Dubocovich
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D003216:Conditioning, Operant / Q000187:drug effects* / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D008124:Locomotion / Q000187:drug effects / Q000235:genetics; D008297:Male; D008550:Melatonin / Q000378:metabolism; D008694:Methamphetamine / Q000494:pharmacology*; D051379:Mice; D008809:Mice, Inbred C3H; D018345:Mice, Knockout; D044122:Receptor, Melatonin, MT1 / Q000172:deficiency* / Q000235:genetics; D044123:Receptor, Melatonin, MT2 / Q000172:deficiency* / Q000235:genetics; D012201:Reward; D013997:Time Factors
chemical_list: D000697:Central Nervous System Stimulants; D044122:Receptor, Melatonin, MT1; D044123:Receptor, Melatonin, MT2; D008694:Methamphetamine; D008550:Melatonin
keywords: C3H/HeN mouse; Conditioned place preference; MT(1) or MT(2) knockout mice; Melatonin; Melatonin receptors